All data are based on the daily closing price as of October 8, 2025
d
Daewoong pharmaceutical
069620.KO
94.42 USD
-2.90
-2.98%
Overview
Last close
94.42 usd
Market cap
1.09B usd
52 week high
123.18 usd
52 week low
72.15 usd
Target price
150.37 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.0228
Price/Book Value
1.8374
Enterprise Value
1.47B usd
EV/Revenue
1.4093
EV/EBITDA
14.2326
Key financials
Revenue TTM
1.04B usd
Gross Profit TTM
539.50M usd
EBITDA TTM
154.02M usd
Earnings per Share
N/A usd
Dividend
0.42 usd
Total assets
1.56B usd
Net debt
422.10M usd
About
Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.